N-Nitroso Deucravacitinib

Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Deucravacitinib, also known as Sotyktu, is a medication used to treat moderate to severe plaque psoriasis in adults 18 and older. Plaque psoriasis is a skin disease that causes red, scaly patches to form on the body. Deucravacitinib is an oral, selective tyrosine kinase 2 (TYK2) inhibitor that works by blocking an abnormal protein that signals cells to multiply.Deucravacitinib is used to treat moderate to severe plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in adults 18 years of age or older whose psoriasis is too severe to be treated by topical medications alone. N-Nitroso Deucravacitinib is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.

N-Nitroso Deucravacitinib CAS NO:NA  chemically  represented as 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)(nitroso)amino)-N-(methyl-d3)pyridazine-3-carboxamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Deucravacitinib . We  supply N-Nitroso Deucravacitinib with detailed characterization data compliance with regulatory guidelines.